WEBULL
News
NLSPW
0.0179
-3.25%
-0.0006
BRIEF-NLS Pharmaceutics Ltd. And Kadimastem Ltd. Announce Completion Of Merger
Reuters · 10/30/2025 21:12
NLS Pharmaceutics and Kadimastem Complete Merger to Form NewcelX
Reuters · 10/30/2025 20:18
NLS Pharmaceutics and Kadimastem Complete Merger and Rebrand as NewcelX
Reuters · 10/30/2025 20:16
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
PR Newswire · 10/30/2025 20:15
NLS Pharmaceutics Expands Pipeline With Aexon Labs Deal
Reuters · 10/30/2025 11:16
NLS Pharma And Aexon Labs Expand DOXA Platform With AEX-6xx Series, New Generation Of Small Molecules Targeting Arousal Stability, Cognition, And Neuroprotection
Benzinga · 10/30/2025 11:15
NLS Pharmaceutics and Kadimastem to Merge Under NewCelX Brand
Reuters · 10/30/2025 11:05
NLS Pharmaceutics and Kadimastem Secure Continued BIRD Foundation Support Following Merger
Reuters · 10/29/2025 11:31
NLS PHARMACEUTICS: FOLLOWING MERGER BETWEEN CO AND KADIMASTEM,COMBINED CO WILL CONTINUE TO ADVANCE ITOL-102 PROGRAM
Reuters · 10/29/2025 11:21
NLS PHARMACEUTICS - COMMON SHARES TO TRADE ON NASDAQ AS NCEL UNDER NEW NAME NEWCELX LTD
Reuters · 10/29/2025 10:00
NLS PHARMACEUTICS - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025
Reuters · 10/29/2025 10:00
NLS PHARMACEUTICS AND KADIMASTEM ANNOUNCE COMPLETION OF MATERIAL CONDITIONS PRECEDENT FOR MERGER TRANSACTION AND DELISTING DATE OF KADIMASTEM'S SHARES
Reuters · 10/29/2025 07:53
NLS Pharmaceutics and Kadimastem Set October 30 Closing for Merger and Nasdaq Listing as NewCelX
Reuters · 10/28/2025 20:38
NLS PHARMACEUTICS AND KADIMASTEM ANNOUNCE STRATEGIC COLLABORATION BETWEEN KADIMASTEM AND TARGETGENE TO ADVANCE NEXT-GENERATION GENE-EDITED CELL THERAPIES
Reuters · 10/27/2025 11:00
Weekly Report: what happened at NLSPW last week (1020-1024)?
Weekly Report · 10/27/2025 10:11
NLS Pharmaceutics Receives Nasdaq Approval for Kadimastem Merger Closing October 30
Reuters · 10/23/2025 10:05
NLS Pharmaceutics, Kadimastem Receive Approval To List Common Shares On Nasdaq After Merger Under NewcelX Name, NCEL Ticker
Benzinga · 10/23/2025 10:04
NLS AND KADIMASTEM ANNOUNCE RECEIPT OF NASDAQ APPROVAL; MERGER EXPECTED TO CLOSE ON OCTOBER 30, 2025
Reuters · 10/23/2025 10:01
Weekly Report: what happened at NLSPW last week (1013-1017)?
Weekly Report · 10/20/2025 10:08
More
Webull provides a variety of real-time NLSPW stock news. You can receive the latest news about NEWCELX LTD through multiple platforms. This information may help you make smarter investment decisions.
About NLSPW
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.